AprilBio Receives Inquiry Disclosure Request Regarding Acquisition Rumor by TK Chemical, Increasing Stock Volatility and M&A Expectations
The KOSDAQ Market Division requested on the afternoon of June 24, 2026 that AprilBio respond to an inquiry disclosure regarding the rumor of being acquired by TK Chemical.
AprilBio must clarify the rumor by 12:00 PM on June 25, 2026, and the response is likely to cause significant stock price movement depending on its content.
TK Chemical is a major domestic conglomerate, and an acquisition could positively impact AprilBio's financial structure and business competitiveness, but currently the rumor is unconfirmed, requiring investor caution.
[AI Summary]This inquiry disclosure request fuels potential M&A expectations, but with no confirmed facts, short-term volatility is expected. If the acquisition rumor is confirmed, the stock price may rise; if denied, expectations could fade, leading to downward pressure.